Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative change in medicine.
Location: France, Ile-de-France, Paris
Employees: 51-200
Total raised: $4.59M
Founded date: 2000
Investors 1
| Date | Name | Website |
| - | IPF Partne... | ipfpartner... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.07.2026 | - | $4.59M | - |
Mentions in press and media 13
| Date | Title | Description |
| 16.07.2026 | Mauna Kea Technologies Secures €4 Million Optional Shareholder Loan To Support Commercial Expansion | Mauna Kea Technologies, a Paris and Boston-based medical device company and inventor of the Cellvizio confocal laser endomicroscopy platform, has established a shareholder loan agreement with long-standing investor Vester Finance for up to ... |
| 13.11.2023 | Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery | MELBOURNE, Australia and PARIS, Nov. 13, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and Paris-based Mauna Kea Technologies (Euronext Growth: ALMKT, Mauna Kea), today announce an expansion of the IRiS (... |
| 05.01.2022 | Mauna Kea Semiconductors (MKSemi) Raises $12.8 Million Pre-A+ Round, Launches Breakthrough Low Power Ultra-Wideband Product | Consumer Electronics Show – Mauna Kea Semiconductors (MKSemi), the leading low power ultra-wideband (UWB) company, today announced the closing of Series Pre-A+ funding totaling $12.8 million led by Lightspeed China Partners with participati... |
| 05.01.2022 | Mauna Kea Semiconductors Raises $12.8M in Pre-A+ Funding | Mauna Kea Semiconductors, a San Jose, CA-based low power ultra-wideband (UWB) company, closed its $12.8m Series Pre-A+ funding. The round was led by Lightspeed China Partners with participation from Qiming Venture and Ivy Capital. Led by Dr... |
| 04.10.2021 | Mauna Kea Technologies : Announces 5 Communications Highlighting the Clinical Value of Cellvizio® in Interventional Pulmonology Presented During the ERS International Congress 2021 | Mauna Kea Technologies Announces 5 Communications Highlighting the Clinical Value of Cellvizio® in Interventional Pulmonology Presented During the European Respiratory Society (ERS) International Congress 2021 Further validation of how Cell... |
| 26.05.2021 | Mauna Kea Technologies : 2020 Year-end financial report | Public Limited Company (Société anonyme) with share capital of €1,223,588 Head office: 9 rue d'Enghien 75010 Paris, France 431 268 028 Trade and Companies Register (RCS) Paris Annual Financial Report 2020 0 CONTENTS CONTENTS Management repo... |
| 26.05.2021 | MAUNA KEA TECHNOLOGIES Mauna Kea Technologies : 2020 Year-end financial report | Public Limited Company (Société anonyme) with share capital of €1,223,588 Head office: 9 rue d'Enghien 75010 Paris, France 431 268 028 Trade and Companies Register (RCS) Paris Annual Financial Report 2020 0 CONTENTS CONTENTS Management repo... |
| 22.04.2021 | MAUNA KEA TECHNOLOGIES Mauna Kea Technologies : sets up an equity financing facility with Kepler Cheuvreux | Mauna Kea Technologies sets up an equity financing facility with Kepler Cheuvreux Paris and Boston, April 22, 2021 - 5:45 PM CEST - Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based... |
| 16.12.2019 | Mauna Kea Technologies Announces Equity Investment of €7.5 Million by Johnson & Johnson Innovation | PARIS & BOSTON--(BUSINESS WIRE)--Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced a s... |
| 06.07.2011 | Mauna Kea beats expectations, closes $70 million IPO | Mauna Kea Technologies announced a successful initial public offering, beating its projections to close at just over $70 million. The offering closed July 4, right on schedule, and its global placement was more than five times oversubscribe... |
Show more